- Home
- ASTI vs BDRX Comparison
ASTI vs BDRX Comparison
Compare ASTI & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- BDRX
- Stock Information
- Founded
- ASTI 2005
- BDRX 2000
- Country
- ASTI United States
- BDRX United Kingdom
- Employees
- ASTI N/A
- BDRX N/A
- Industry
- ASTI Semiconductors
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- BDRX Health Care
- Exchange
- ASTI Nasdaq
- BDRX Nasdaq
- Market Cap
- ASTI 2.9M
- BDRX 5.8M
- IPO Year
- ASTI N/A
- BDRX N/A
- Fundamental
- Price
- ASTI $1.85
- BDRX $0.88
- Analyst Decision
- ASTI
- BDRX
- Analyst Count
- ASTI 0
- BDRX 0
- Target Price
- ASTI N/A
- BDRX N/A
- AVG Volume (30 Days)
- ASTI 6.7M
- BDRX 4.2M
- Earning Date
- ASTI 08-05-2025
- BDRX 04-11-2025
- Dividend Yield
- ASTI N/A
- BDRX N/A
- EPS Growth
- ASTI N/A
- BDRX N/A
- EPS
- ASTI N/A
- BDRX N/A
- Revenue
- ASTI $51,917.00
- BDRX N/A
- Revenue This Year
- ASTI N/A
- BDRX N/A
- Revenue Next Year
- ASTI N/A
- BDRX N/A
- P/E Ratio
- ASTI N/A
- BDRX N/A
- Revenue Growth
- ASTI N/A
- BDRX N/A
- 52 Week Low
- ASTI $1.10
- BDRX $0.78
- 52 Week High
- ASTI $10.45
- BDRX $30.00
- Technical
- Relative Strength Index (RSI)
- ASTI 46.99
- BDRX 42.16
- Support Level
- ASTI $2.10
- BDRX $0.82
- Resistance Level
- ASTI $2.64
- BDRX $1.33
- Average True Range (ATR)
- ASTI 0.50
- BDRX 0.09
- MACD
- ASTI -0.05
- BDRX 0.02
- Stochastic Oscillator
- ASTI 27.17
- BDRX 11.75
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.